Medtronic stock holds firm after dividend and earnings update.
Published on 08/21/2026 at 11:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medtronic plc (IE00BTN1Y115) held a market value of $118.33 billion on August 21, 2026, while the shares opened at $92.45 and the company carried a price-to-earnings ratio of 24.79. The immediate backdrop is a new $0.72 quarterly dividend approved on August 20, 2026, plus a June 3, 2026 quarter that produced $9.81 billion in revenue and $1.55 in adjusted EPS.
Dividend and valuation
The dividend works out to a forward yield of 3.12% and was set alongside a record that included $9.81 billion in quarterly sales, 9.9% year-over-year revenue growth, and EPS of $1.55 versus $1.54 expected. That mix gives investors both income and a valuation anchor, with the stock trading at 24.79 times earnings.
Latest reported quarter
The June 3, 2026 update also showed a net margin of 13.20% and return on equity of 14.51%, both figures that help frame the latest operating run-rate. Revenue topped the $9.62 billion estimate by $190 million, while EPS beat by $0.01.
Product line
In its medical-device portfolio, Medtronic continues to lean on therapies spanning cardiovascular, neuroscience, and surgical technologies, with the latest quarter showing that the business can still convert scale into profit. The dividend decision and the June quarter's 9.9% revenue gain leave the stock positioned as a defensive large-cap name with measurable cash returns.
Shares and payout
As of August 21, 2026, the shares were priced at $92.45 and the market cap stood at $118.33 billion. The new quarterly payout of $0.72 is payable on October 16, 2026, to shareholders of record on September 25, 2026.
Fact box
Company: Medtronic plc
ISIN: IE00BTN1Y115
Ticker: MDT
Exchange: NYSE
Price (as of August 21, 2026): $92.45 USD
Market cap: $118.33 billion
Sector / Industry: Health Care / Health Care Equipment & Supplies
